The federal judge who ruled last month that the Affordable Care Act (ACA) was invalid issued an order over the weekend that the law will remain in effect pending appeal; pharmacies and businesses with pharmacies in New York City will no longer be allowed to sell cigarettes and other tobacco products; a federal judge has blocked the administration's cut to the 340B program.
The federal judge who ruled last month that the Affordable Care Act was unconstitutional issued a stay over the weekend, which will keep the law in effect while the ruling is appealed. According to The New York Times, Judge Reed O’Connor of the Federal District Court in Fort Worth, Texas, said that the ruling would not go into immediate effect “because many everyday Americans would otherwise face great uncertainty” during the appeal.
Starting this week, pharmacies and businesses that contain pharmacies, such as supermarkets, will be banned from selling cigarettes and other tobacco products in New York City, reported The Wall Street Journal. Affecting approximately 500 pharmacies, the change will reduce the total number of retailers licensed to sell tobacco by about 6.4%. Health officials in the city praised the decision, calling it an important step in reducing the number of smokers in New York.A federal judge has blocked the Trump administration’s cut to the 340B Drug Discount Program, ruling that the administration illegally reduced Medicare payments to the program and that the rule went against Congress’s intent when it approved the program, reported The Hill. The rule, which went into effect last January, cut payments by 30%. When the rule was issued, the administration argued that the changes would reduce out-of-pocket costs Medicare patients pay for outpatient drugs. However, hospitals argued that the changes would threaten critical services they provide to underserved populations.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More